Milart Prescription Pharmacy is categorized under in Beverly Hills, CA and active since 1953.
Milart Prescription Pharmacy was established in 1953, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Ari Levian, Owner at the company’s single location by writing to 300 South Beverly Drive # 100, Beverly Hills, California CA 90212 or by phoning (310) 553-0225. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Milart Prescription Pharmacy |
| Contact Person: | Ari Levian, Owner |
| Address: | 300 South Beverly Drive # 100, Beverly Hills, California 90212 |
| Phone Number: | (310) 553-0225 |
| Website Address: | milartpharmacy.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1953 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Milart Prescription Pharmacy was started in 1953 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Ari Levian, Owner for inquiries that concern Milart Prescription Pharmacy by calling the company number (310) 553-0225, as your correspondence is most welcome. Additionally, the physical location of the single location of Milart Prescription Pharmacy can be found at the coordinates 34.0611,-118.39921 as well as the street address 300 South Beverly Drive # 100 in Beverly Hills, California 90212.
For its online presence, you may visit Milart Prescription Pharmacy’s website at milartpharmacy.com and engage with its social media outlets through on Twitter and on Facebook.